...
首页> 外文期刊>Clinical and experimental allergy : >IgE promotes type 2 innate lymphoid cells in murine food allergy
【24h】

IgE promotes type 2 innate lymphoid cells in murine food allergy

机译:IgE促进鼠食物过敏的2型先天淋巴细胞

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Summary Background Mast cells serve an important sentinel function at mucosal barriers and have been implicated as key early inducers of type 2 immune responses in food allergy. The generation of Th2 and IgE following food allergen ingestion is inhibited in the absence of mast cells. Group 2 innate lymphoid cells are also thought to play an important early role in nascent allergic responses. Objective To test whether IgE‐mediated mast cell activation promotes intestinal ILC 2 responses following ingestion of food allergens and whether ILC 2 amplify food allergy. Methods Two different mouse models of food allergy, one using intraperitoneally ovalbumin ( OVA )‐primed BALB /c animals and the other using enterally peanut‐sensitized inherently atopic IL 4raF709 mice, were applied to test the contributions of IgE antibodies and mast cells to ILC 2 responses. The effect of ILC 2 on mast cell activation and on anaphylaxis was tested. Results ILC 2 responses were significantly impaired in both models of food allergy in Igh7 ?/? mice harbouring a targeted deletion of the gene encoding IgE. A similar reduction in food allergen‐induced ILC 2 was observed in mast cell‐deficient Il4raF709 Kit W‐sh mice, and this was partially corrected by reconstituting these animals using cultured bone marrow mast cells. Mast cells activated ILC 2 for IL ‐13 production in an IL ‐4Rα?dependent manner. Activated ILC 2 amplified systemic anaphylaxis by increasing target tissue sensitivity to mast cell mediators. Conclusions and Clinical Relevance These findings support an important role for IgE‐activated mast cells in driving intestinal ILC 2 expansion in food allergy and reveal that ILC 2, in turn, can enhance responsiveness to the mediators of anaphylaxis produced by mast cells. Strategies designed to inhibit IgE signalling or mast cell activation are likely to inhibit both type 2 immunity and immediate hypersensitivity in food allergy.
机译:发明内容背景肥大细胞在粘膜屏障中提供重要的哨兵函数,并且涉及食物过敏2型免疫应答的关键早期诱导剂。在没有肥大细胞的情况下抑制了食物过敏原摄入后的Th2和IgE的产生。第2组先天淋巴细胞也被认为在新生过敏反应中发挥着重要的早期作用。目的测试IgE介导的肥大细胞活化是否促进食用过敏原后促进肠道ILC 2反应,以及ILC 2是否扩增食物过敏。方法采用两种不同小鼠模型的食物过敏,一种使用腹膜内卵蛋白(OVA) - 预期的BALB / C动物和使用肠道花生敏化的Altopic IL 4RAF7R709小鼠,用于测试IgE抗体和肥大细胞对ILC的贡献2回应。测试ILC 2对肥大细胞活化和过敏症的影响。结果ILC 2在IGH7中的食物过敏模型中显着损害了答案?/?患有编码IgE的靶向缺失的小鼠。在肥大细胞缺陷IL4RAF709试剂盒W-SH小鼠中观察到类似食物过敏原诱导的ILC 2的减少,并且通过使用培养的骨髓肥大细胞重构这些动物,部分校正。肥大细胞以IL-4Rα的IL -13产生的ILC 2激活ILC 2。依赖性方式。通过增加对肥大细胞介质的靶组织敏感性,激活ILC 2扩增的全身性过敏。结论和临床相关性这些发现对于IgE-活化的肥大细胞在驱动肠道ILC 2中的膨胀中的膨胀中的膨胀性和揭示ILC 2反过来可以增强对由肥大细胞产生的过敏反应器的反应性的重要作用。设计用于抑制IgE信号或肥大细胞活化的策略可能抑制食物过敏的2型免疫和立即过敏。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号